Access to the DuoBody technology for academic research
We encourage the use of Genmab’s DuoBody technology for academic research and can provide support for the generation of bispecific antibodies with this technology upon acceptance of terms and conditions of use. The DuoBody technology provides a versatile approach for the generation of bispecific antibodies for research.
Protocols are described in:
-Labrijn et al, PNAS 2013 (Duobody technology)
-Labrijn et al. Nature Protocols 2014 (Protocol)
-Gramer et al, mAbs 2013 (Bioreactor process)
-Vink et al, Methods 2014 (Transient antibody expression)
If you would like to receive support to begin working with the technology, or need help with certain steps during the process, you can contact us. Fill in the form below if you need help with, or have questions regarding the preparation of expression vectors, antibody expression, purification or the controlled Fab-arm exchange process. One of our expert scientists will provide you with advice within 5 business days¹.
You can also indicate in the ‘Question’ box that you only wish to obtain an academic research license now, which gives you the opportunity to ask technical questions at any time later1.
¹ within the terms and conditions stipulated
Please note that the personally identifiable information that you provide to Genmab A/S through this website may be processed by Genmab A/S’ affiliated companies, including without limitation affiliated companies located in the US. By providing your personally identifiable information below you consent to the processing of the information by Genmab A/S’ affiliated companies.